Purpose. Neonatal sepsis caused by Streptococcus agalactiae [group B streptococcus (GBS)] is a life-threatening condition, which is preventable if colonized mothers are identified and given antibiotic prophylaxis during labour. Conventional culture is time consuming and unreliable, and many available non-culture diagnostics are too complex to implement routinely at point of care. Loop-mediated isothermal amplification (LAMP) is a method that, enables the rapid and specific detection of target nucleic acid sequences in clinical materials without the requirement for extensive sample preparation.
INTRODUCTION
Streptococcus agalactiae [group B streptococcus (GBS)] is the leading cause of early-onset neonatal sepsis [1] [2] [3] [4] [5] . Asymptomatic GBS colonization of the vagina and lower gastrointestinal tract occurs in 10-30 % of pregnant women and is the most significant risk factor for neonatal GBS disease, as transmission can occur from the recto-vaginal area during childbirth [4, [6] [7] [8] [9] . The implementation of culture-based antepartum screening programmes for all pregnant women at 34-38 weeks and initiation of intrapartum antibiotic prophylaxis has helped to reduce, but not eliminate, neonatal early-onset disease in many industrialized countries [4, 10, 11] .
Despite technological advances, the primary method for the detection of GBS colonization remains selective laboratory-based culture of vaginal and/or rectal swab specimens followed by ancillary confirmation tests. This approach demonstrates variable sensitivity [12] [13] [14] and is associated with long turn-around times of 18-72 h, rendering culture unfeasible as an intrapartum test. Thus, women who give birth prematurely are not screened, and women who become colonized after screening are not identified [7, 8] . A sensitive screening assay that could rapidly determine GBS status during labour would be beneficial as it would facilitate targeted therapy while reducing the risks associated with antibiotic use in noncolonized women [15] .
Quantitative real-time PCR (qPCR) assays can provide test results in a few hours [15] [16] [17] [18] [19] [20] . However, requirements for expensive equipment, intricate sample preparation, skilled staff and support preclude the use of PCR at point of care (POC) [21] [22] [23] .
Loop-mediated isothermal amplification (LAMP) is an isothermal molecular amplification technique that offers simple qualitative detection combined with exceptional sensitivity and specificity [24] [25] [26] . The single reaction temperature (60-65 C) employed by LAMP means that there are no requirements for thermocycling, resulting in a need for less complex equipment making it amenable to use at POC [22, 27] . Furthermore, compared to PCR, LAMP is also demonstrably more resistant to inhibitors found in clinical material, indicating its potential for direct application to clinical specimens and/or crude sample preparations [21, 28, 29] . This is advantageous as one of the issues frequently hampering the application of nucleic acid amplification tests (NAATs) at POC is the requirements to perform dedicated multi-step nucleic acid (NA) extraction, which adds to test complexity, cost and turn-around time [21] [22] [23] . While a number of LAMP assays for GBS detection have been developed previously, these are not amenable for POC use having requirements for an 18-24 h pre-enrichment culture step [20] , require multiple timeconsuming manipulations prone to contamination [30] or have unproven clinical efficacy [31, 32] .
Here, we describe a newly designed GBS LAMP assay targeting the Streptococcus agalactiae sip gene. As a proof of concept, the LAMP assay was applied to residual vaginal swabs that had undergone minimal sample processing (direct detection -no extraction protocol) with a rapid-lysis solution containing the bacteriolytic enzyme achromopeptidase (ACH). ACH demonstrates high lytic activity against a range of Gram-positive cocci, including GBS [23, [33] [34] [35] .
METHODS

Clinical specimens
The study was approved by the Office for Research Ethics Committee Northern Ireland (reference 09/NIR02/43). A total of 157 residual vaginal swabs from pregnant women submitted to the Department of Microbiology, Belfast Health and Social Care Trust (BHSCT) for bacterial investigations between March and July 2013 were opportunistically collected and utilized for the clinical validation study. The sample set consisted of 153 high vaginal swabs and 4 low vaginal swabs. All vaginal swabs were collected on plastic rayon-tipped swabs (Sterilin) and transported to the laboratory in AMIES transport medium. Culture of all swab specimens was carried out according to the BHSCT Standard Operating Procedure by the laboratory staff, who were unaware that the samples were to be subsequently included in a study. Briefly, each swab was plated onto Columbia blood agar (CBA) and differential Granada agar (bio-M erieux). CBA plates were incubated in a 10 % CO 2 atmosphere with Granada plates incubated anaerobically at 37 C. Plates were examined at 18-24 h and again at 48 h, with presumptive positive GBS colonies on Granada agar identified by the production of orange pigment. Presumptive GBS colonies on CBA were identified on the basis of haemolysis. All suspect colonies were appropriately identified by a combination of standard tests including Gram stain, catalase activity and latex agglutination using a SLI-DEX Strepto Plus kit (bioM erieux) to identify the presence of group B antigen. Following routine bacteriological culture, all residual swabs were stored at 4 C for a maximum of 1 week until processing and molecular analysis.
Rapid sample preparation method for direct LAMP The lysis solution consists of 10 U l À1 ACH in 10 mmol l À1 Tris/HCl pH 8.0 and 1 mmol l À1 EDTA (Sigma-Aldrich). Residual swab specimens were removed from AMIES transport medium tubes with~2 cm of the end physically broken off into 400 µl pre-aliquoted lysis solution (ACH) by firmly pressing the swab against the side of a microfuge tube (Sarstedt). Tubes were capped and swabs incubated at ambient 'room temperature' (22) (23) (24) C) for 5 min before boiling at 95 C for 5 min in a dedicated heat block to simultaneously deactivate ACH and denature any target DNA for LAMP analysis. Samples were immediately cooled by placing directly on ice. A 5 µl aliquot of lysis supernatant was used for GBS direct LAMP testing as outlined below. The remaining lysis supernatant was stored at 4 C.
NA extraction for qPCR and indirect LAMP GBS reference and clinical isolates were pre-treated with ACH before undergoing total NA extraction using a QIAamp Blood DNA Mini Extraction kit (Qiagen). A 200 µl saline suspension of each GBS isolate was prepared and added to an equal volume of ACH (20 U l
À1
) for a final working concentration of ACH (10 U l À1 ). The suspension was incubated at room temperature for 5 min before being boiled at 95 C for 5 min. A two hundred-microlitre aliquot of each lysate was then added to AL lysis buffer (Qiagen) and processed as per the manufacturer's instructions to produce 100 µl of genomic extract.
Bacterial and fungal genomic DNA for specificity evaluation were obtained using a QIAamp Blood DNA Mini Extraction kit (Qiagen). A two hundred-microlitre saline suspensions of each target organism was added to AL lysis buffer and processed as per the manufacturer's instructions to produce 100 µl of genomic extract.
Vaginal swab lysates were extracted as follows: a 200 µl aliquot of ACH lysis supernatant (produced as indicated above) was removed from each clinical swab specimen and extracted using a MagNA Pure 96 Viral NA Small Volume kit and MagNA Pure Instrument (Roche Diagnostics) as per the manufacturer's instructions. The resultant 100 µl genomic extract aliquots were stored at À80 C until required for qPCR and LAMP (indirect) analysis.
LAMP primers and reaction LAMP primers targeting a highly conserved region of the Streptococcus agalactiae sip gene (HiberGene Diagnostics) were employed throughout. The LAMP primer set consisted of forward (sip_FIP) and reverse (sip_BIP) 'inner' primers, forward (sip_F3) and reverse (sip_B3) 'outer' primers, and forward (sip_FL) and reverse (sip_BL) 'loop' primers. Optimized GBS LAMP consisted of 5 µl template DNA, 12.5 µl LAMP isothermal Master Mix ISO 001 (OptiGene) containing novel strand-displacing DNA polymerase (GspSSD), propriety thermostable inorganic pyrophosphatase, reaction buffer, MgCl, dNTPs, DNA-intercalating dye, 2 µM each of FIP and BIP, 0.2 µM each of F3 and B3, 1 µM each of FL and BL, and Nuclease-Free Water (Promega) for a final reaction volume of 25 µl. The GENIE II (OptiGene) real-time fluorometer was utilized for concurrent target isothermal amplification and detection. LAMP reactions were performed at a previously identified optimal reaction temperature of 62 C for 30 min, followed by a heating and cooling step for 98-80
), which allows reannealing of amplified DNA and display of a specific annealing curve. Positive and negative controls were included for each run, and stringent precautions undertaken to prevent cross-contamination. Positive LAMP reactions were identified by GENIE II (OptiGene) instrument software. Each positive reaction had a time to positivity (T T ) value in minutes and seconds and a specific melting point temperature (T m ) in degrees centigrade ( C).
qPCR qPCR was employed as the reference molecular detection method. Primer and hybridization probe sequences targeting the Streptococcus agalactiae sip gene were as previously described [17] . Primer sequences are as follows: forward primer 5¢-ATCCTGAGACAACACTGACA-3¢ and reverse primer 5¢-TTGCTGGTGTTTCTATTTTCA-3¢. The hybridization probe 5¢-ATCAGAAGAGTCATACTGCCACTTC-3¢ contained a 6-carboxyfluorescein label on the 5¢ end with a Black Hole Quencher 1 (BHQ1) on the 3¢ end. The primers and hybridization probe were synthesized by Eurogentec. The final qPCR mix contained 1Â Platinum UDG Mastermix (Life Sciences), 0.2 µM BSA (Sigma), 4 mmol l À1 MgCl 2 , 0.4 µM forward and reverse primers, 0.2 µM hybridization probe, Nuclease-Free Water (Promega) and 3 µl of target template, for a final reaction volume of 12 µl. qPCR was performed using a Light Cycler 480 (LC480) instrument (Roche Diagnostics). A no-template control (NTC) consisting of Nuclease-Free Water (Promega) and a plasmid reference standard containing 3.50e06 sip genome copies ml À1 were included for all qPCR runs. The qPCR run parameters consisted of an initial step of 95 C for 10 min followed by an amplification programme for 45 cycles of 10 s at 95 C and 30 s at 60 C, 1 s at 72 C, with fluorescence acquisition at the end of each extension. Data were analysed using LC480 software, and the GBS genome copy number for positive specimens determined from the crossing point threshold (Cp) relative to an external positive control curve.
Specificity and sensitivity Specificity of GBS LAMP was evaluated using total genomic extracts (containing approximately 10e07 genome copies) derived from a range of bacteria (n=55) and fungi (n=1). These included a number of GBS reference, clinical and veterinary isolates (n=17). Reaction mix without DNA template was included as a negative control. 
Statistical analysis
For the purposes of validation, the reference molecular method was defined as ACH pre-treatment of a clinical swab specimen followed by NA extraction and qPCR testing. A specimen was considered a true positive if: (i) GBS was obtained following culture or (ii) the specimen was identified as GBS qPCR positive. All qPCR and LAMP results were compared to routine culture results. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and positive (LR+) and negative (LRÀ) likelihood ratios for each test method were calculated. The level of agreement between LAMP and qPCR assays was assessed using the kappa (k) coefficient with 95 % confidence levels. k was calculated using the formula [Pr(o)ÀPr (e)]/[1ÀPr(e)], where Pr(o) is the observed agreement and Pr(e) is the hypothetical probability of chance agreement.
RESULTS
Analytical reactivity, specificity and sensitivity The LAMP assay successfully amplified DNA from all GBS reference, clinical and veterinary strains analysed, with T T values of less than 20 min and specific melt point temperature values (T m ) ranging from 85.5 to 86. 21 C obtained. No amplification was recorded for any other bacterial or fungal species tested. This confirmed the 100 % specificity of the GBS LAMP assay.
Employing 10-fold serial dilutions of a known concentration (2.8e07 to 2.8e02 copies ml
À1
) of GBS ATCC 12386 NA extracts in duplicate, the LAMP assay consistently detected 2.80e03 sip genome copies ml À1 corresponding to an analytical LOD of 14 genome copies per reaction (for 5 µl input volume and final reaction volume of 25 µl). The mean GBS LAMP T T and T m for 2.80e03 sip genome copies ml À1 were determined as 11 min and 85.98 C, respectively. The LAMP LOD was slightly higher than that achieved for qPCR, which in our laboratory had a previously determined LOD of 1.00e03 genome copies ml À1 equating to two genome copies per reaction.
Clinical validation
Routine bacteriological culture was compared to the reference qPCR molecular method, direct LAMP and indirect LAMP methods. A summary of the findings is outlined in Tables 1  and 2 . A total of 36/157 (22.9 %) specimens analysed were confirmed as GBS culture positive. All 36 culture-positive GBS specimens were correctly identified as positive by qPCR and by the direct and indirect LAMP methods. An additional seven specimens were identified as GBS positive by qPCR, giving a total of 43/157 (27.4 %) 'true' positive specimens. Comparison of difference between qPCR and culture results was statistically significant (P=0.0005). The loads of GBS determined by qPCR (genome copies per millilitre) for positive clinical specimens were as follows: mean=1.23e+08; max. =2.50e+09; min.=1.90e+03; median=2.40e+06. Compared to culture, qPCR had a sensitivity and specificity of 100 and 94.2 %, respectively, with a PPV and NPV of 83.7 and 100 %, respectively. LR+ and LRÀ were infinity and 0.16, respectively. The mean of genome copies per millilitre of the seven identified specimens missed by culture but positive by qPCR was 1.09e06 (range 1.90e03 to 7.60e06; median 5.50e03) compared to 1.47e08 (range 4.60e03 to 2.50e09; median 3.65e06) for specimens identified as both culture and qPCR positive. This difference in mean genome copies per millilitre was statistically significant (P 0.0001).
The direct LAMP method required a mean time of 45 min from receipt of a swab to generation of a confirmed result, compared to 1 h 45 min for indirect LAMP (extraction protocol) and 2 h 30 min for the reference qPCR test. Table 1 . Perfomance of LAMP (indirect and direct) and culture testing for clinical swabs (n=157) compared to reference GBS qPCR method For LAMP, the mean, maximum, minimum and median times required to achieve LAMP positivity in minutes: (T T ) and specific melt temperatures (T m ) in degrees centigrade are shown. sensitivity and specificity of 100 % and a PPV and NPV of 100 %. LR+ and LRÀ likelihood ratios were infinity and 0.00, respectively. Compared to qPCR, the direct LAMP had a sensitivity and specificity of 95.4 and 100 % with a PPV and NPV of 100 and 98.3 %, respectively. LR+ and LRÀ likelihood ratios were infinity and 0.05, respectively. Two specimens (405 and 453, see Table 2 ) were identified as false negative after analysis by the direct LAMP method. Following NA extraction and analysis by qPCR, these specimens tested GBS positive with genome copy loads of 1.90e +03 ml À1 (9.5 copies per 5 µl addition) and 1.91e+03 ml À1 (9.6 copies per 5 µl addition), respectively. Additionally following NA extraction both of the specimens tested LAMP positive, returning T T values of 12.15 and 29.00 min, respectively. Overall the mean time to achieve positivity (T T ) for the direct LAMP method was higher then the indirect LAMP method: 14.83 min (range 8.15 to 26.00 min) compared to 9.60 min (range 5.00 to 29.00 min). Testing of performance comparison is displayed in Table 1 , with all specimens identified as positive by either culture, qPCR and/or LAMP presented in Table 2 .
GBS qPCR LAMP (indirect) LAMP (direct) Culture
DISCUSSION
Screening for maternal GBS colonization at 35-37 weeks via selective culture is a time-consuming and inadequate method that fails to identify all cases of GBS [12, 13, 20] .
There is a recognized clinical need for rapid, highly sensitive and specific methods to detect GBS which can be used at POC before or during labour to identify women for prophylactic antibiotic treatment. Currently qPCR offers the required specification to achieve these goals; however, technical obstacles, including requirements for stringent sample preparation, complex instrumentation and skilled personnel, have restricted their introduction at POC [21] [22] [23] . The robust chemistry, ease of operation, rapidity, low cost and modest equipment requirements associated with LAMP represent significant advantages over existing molecular methods for detection of pathogens [22, 27, 29, 36] .
The primary objective of this proof of concept study was to validate the effectiveness of a prototype LAMP assay (HiberGene Diagnostics) in combination with a simple rapid specimen lysis protocol (without extraction) for direct detection of GBS in residual vaginal swabs. Pre-lysis with ACH at a concentration of 10 U l À1 for 5 min at room temperature has previously been shown in our laboratory to be a highly effective method to significantly increase the available yield of GBS NA for molecular analysis [35] . Eliminating the requirement for NA extraction not only simplified the test procedure but also resulted in significant time savings, with direct LAMP taking 45 min from receipt of swab to definitive GBS result compared to 60 min and >2 h for indirect LAMP and qPCR, respectively. The GBS LAMP assay had an analytical LOD of 2.80e03 genome copies ml
À1
, which compares favourably with the determined reference qPCR analytical LOD of 1.00e03 genome copies ml
. Crucially when applied to clinical specimens, qPCR and both direct and indirect LAMP methods resulted in identification of additional GBS positives (n=7) missed by culture. These findings were not unexpected, and are consistent with previous studies demonstrating an increase in GBS positivity rate when NAATs are directly compared to culture [13, 16, [18] [19] [20] . Higher detection rates of NAATs have been claimed to be due to the inability of culture to detect low numbers of GBS bacteria, but may also be attributed to the presence of antagonistic flora and/or the detection of non-culturable cells [19, 37] .
Compared to the reference qPCR method, the direct LAMP had a sensitivity of 95.4 and specificity of 100 %. High specificity is an intrinsic feature of LAMP, and reflects the presence of six specific LAMP, primers recognizing eight target regions on the sip gene. The direct LAMP assay returned higher mean T T values for identified positive specimens compared to the indirect LAMP assay applied to the same samples that had undergone NA extraction (14.69 versus 9.61 min, respectively -a difference of 5.08 min). Additionally the direct LAMP assay failed to detect GBS in two specimens subsequently shown to contain low genomic loads by qPCR. These findings indicate that the presence of component(s) in crude lysate matrices can impede LAMP and, in conjunction with low initial GBS loads, may have contributed to the two false-negative results. Solution(s) to combat this could include prior centrifugation and/or a dilution step(s), although this would complicate the assay protocol and make application less attractive at POC. At present the clinical significance of specimens containing a low GBS burden remains to be determined [16] . The excellent performance of qPCR and LAMP in this study must also be taken in context, as 'second-hand' residual vaginal swabs post-bacteriological culture as described would certainly benefit from further field evaluation employing dedicated recto-vaginal swabs, in order to fully establish diagnostic and analytical characteristics. Efforts are currently under way to address this.
While this study utilized a GENIE II fluorometer (cost £5000) to conduct isothermal amplification and specific detection of GBS in real time, it would be entirely feasible to perform GBS LAMP testing using a simple heating block in conjunction with simple visual endpoint interpretation. This represents a commonly applied and valid approach for LAMP testing, particularly in resource-limited settings [27, 38, 39] .
In conclusion, the data presented demonstrate the efficacy of employing LAMP on minimally processed vaginal swabs for rapid direct molecular detection of GBS. The simplicity of the direct LAMP protocol, combined with the described sensitivity and specificity, are desirable characteristics amenable to POC use in resource-limited settings.
